Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Portfolio rejig: Exiting IG Petrochem Thirumalai as import protection may end

2018-07-13 moneycontrol
The growth outlook for phthalic anhydride (PA) chemicals is one such area which has caught our attention. While the PA domestic industry, dominated by IG Petrochem and Thirumalai Chemicals, is driven by robust end markets of poly vinyl chloride (PVC), resins and pigments, the possibility of higher inexpensive import of PA is a cause for concern. On account of this, we are exiting our portfolio exposure to IG Petrochem and Thirumalai Chemicals in our midcap and Diwali portfolio, respectively.
TIRUMALCHM 500412

0
Can the chemical industry benefit from US-China trade war?

2018-07-11 moneycontrol
A potential lowering of import tariffs by China for Indian chemicals is a positive and doesn’t seem to be a chip off from the US-China trade war. China’s own strategic interest, supply-side reforms, focus on higher value added chemicals are key imperatives behind such a scenario.
TIRUMALCHM 500325 RELIANCE RIGD 500412 RLNIY

0
Thirumalai Chemicals Limited - Trading Window

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TIRUMALCHM 500412

0
Thirumalai Chemicals Limited - Shareholders meeting

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TIRUMALCHM 500412

0
Thirumalai Chemicals Limited - AGM/Book Closure

2018-06-27 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TIRUMALCHM 500412

0
Thirumalai Chem CFO Krishnamoorthy resigns

2018-05-29 thehindubusinessline
Thirumalai Chemicals has, under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informed the exchanges that the chemical-maker’s Chief Financial Officer P. Krishnamoorthy has resigned from the company. He will be relieved of his duties as on May 31, 2018. The stock of Thirumalai Chemicals closed at ₹1,672.70, up 1.13 per cent over its previous close on the BSE.
TIRUMALCHM 500412

0
Thirumalai Chemicals Limited - Updates

2018-05-23 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TIRUMALCHM 500412

24
Market Live: Sensex falls 250 pts, Nifty breaks 10,600; rupee extends losses

2018-05-04 moneycontrol
Earnings: Ambuja Cements has reported standalone profit at Rs 271.8 crore for the quarter ended March 2018, a growth of 10.3 percent over Rs 246.5 crore reported in year-ago.
BAJAJ-AUTO 500325 500820 500425 533150 RELIANCE ATB 532977 HDFC BHRQY AMBUJACEM ASIANPAINT 532215 532541 AMBUY AXISBANK 506590 RIGD PHILIPCARB 500412 BHARTIARTL 500010 RLNIY NIITTECH YESBANK HINDALCO CARBORUNIV AXB 532648 YYBKY 513375 AXBKY TIRUMALCHM HNDNF 532454 AXBA GODREJPROP 534809 PCJEWELLER HDFC 500440

0
Thirumalai Chemicals Limited - Auditor's report

2018-05-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
TIRUMALCHM 500412

0
Thirumalai Chemicals gains 6% stock split recommendation, better Q4 PAT

2018-05-04 moneycontrol
Share price of Thirumalai Chemicals gained 6 percent intraday Friday as recommends sub division of equity share.
TIRUMALCHM 500412

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

18h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...